Efgartigimod for the treatment of Lambert–Eaton syndrome: a case report

Conflicts of interest

The authors have no financial or proprietary interests in any material discussed in this article.

Ethical approval

This report has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Our patient provided written informed consent according to the Declaration of Helsinki. Our study obtained approval from Ethics committee of Medical Science Research, Affiliated Hospital of Jining Medical University, Jining, Shandong Province, China (Reference number, 2025–02-C029).

Consent for publication

All authors had full access to the data in the case report and had final responsibility for the decision to submit for publication.

Comments (0)

No login
gif